FDA WARNING_LETTER - Ecig.com
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA issued a Warning Letter to Stefan Gol regarding the sale of e-liquid products on ecig.com. The Center for Tobacco Products determined that "The Drip Company Triple Berry e-liquid" is a tobacco product under section 201(rr) of the FD&C Act and is misbranded under section 903(a)(7)(B) because it was sold to a person younger than 18 years of age.
This sale violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquids, to individuals under 18. The FDA's investigation confirmed a minor purchased the specified e-liquid from the website.
The letter requires immediate correction of this violation and similar issues, ensuring all tobacco products, labeling, and advertising comply with the FD&C Act and FDA regulations across all sales channels. Failure to comply may result in civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, or injunction. A written response detailing corrective actions and a compliance plan is required within 15 working days, referencing number RW1700764.
- Company
- Ecig.com
- Product Type
- Tobacco
ID · 6da4218a-c4fb-47d6-a68d-01e6645714d3
Full citation text and observation details available on the Dashboard.